Derek Small - Assembly Biosciences Insider

Assembly Biosciences Inc -- USA Stock  

USD 59.67  2.69  4.31%

Co-Founder, CEO and President and Director

Mr. Derek A. Small is President, Chief Executive Officer, Director of ASSEMBLY BIOSCIENCES, Inc. Mr. Small is a cofounder of Assembly Pharmaceuticals, and has served as Executive Chairman of the company since inception in 2012. From March 2008 to January 2014, Mr. Small served as a founding director, President, and Chief Executive Officer of Naurex, Inc., a privately held biotechnology company. From January 2009 to April 2012, Mr. Small also served as founding director, President, and Chief Executive Officer to Coferon, Inc., a privately held biotechnology company. Each of these companies was founded as portfolio companies of Luson Bioventures, a biotechnology and biopharmaceutical venture creation firm that Mr. Small founded in 2007. Mr. Small continues to serve on the Board of Directors of Naurex, Inc
Age: 38  CEO Since 2015      
Small received his BS in Business from Franklin College, including participation in the Harlaxton College affiliate program in England.

Management Efficiency

The company has return on total asset (ROA) of (24.41) % which means that it has lost $24.41 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (44.36) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 8 records

CEO Since

Jeffrey BachaDelMar Pharmaceuticals Inc
Jeff BaxterVBI Vaccines Inc
Curtis LockshinVBI Vaccines Inc
Ryan WattsDenali Therapeutics Inc
Barry SimonNantKwest Inc
MRCP MBBSDimension Therapeutics Inc
Dror HaratsVascular Biogenics Ltd
Annalisa JenkinsDimension Therapeutics Inc

Entity Summary

Assembly Biosciences, Inc. operates as a clinical stage biotechnology company. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in Carmel, Indiana. Assembly Biosciences operates under Drug Manufacturers - Major classification in USA and traded on Nasdaq Capital Markets exchange. It employs 79 people.Assembly Biosciences Inc (ASMB) is traded on Nasdaq Capital Markets in USA. It is located in NEW YORK, U.S.A and employs 79 people. Assembly Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Assembly Biosciences Inc to your portfolio

Top Management

Assembly Biosciences Inc Leadership Team
Uri Lopatin, President, Ph.D
Helen Kim, Director, MBA
Myron Holubiak, Director
Lee Arnold, Executive, Ph.D
Anthony Altig, Director
Richard Colonno, Executive
Graham Cooper, COO, MBA
William Ringo, Chairman, MBA
Susan Mahony, Director
Richard DiMarchi, Director, Ph.D
Miguel Barbosa, Executive, Ph.D
Thomas Rollins, Executive
Mark Auerbach, Director
Derek Small, CEO
Alan Lewis, Director, Ph.D
David Barrett, COO

Stock Performance

Assembly Biosciences Performance Indicators